7.0 BIOLOGICAL
AGENTS
7.1 General
Many laboratory practices and requirements are common to laboratories
using chemical and biological agents. The laboratory procedures described
in Section 5.0, "General Laboratory Safety,"
and Section 6.0, "Chemical Hazards,"
also apply to laboratories using biological agents, and that information
will not be repeated in this part. Most of the information in this section
is taken from the book Biosafety in Microbiological and Biomedical
Laboratories (U.S. Health and Human Services Publication No. CDC93-8395,
Public Health Service, Centers for Disease Control and Prevention, and
National Institutes of Health, 1999). A copy of the book is available
for reference in ORS.
Biological agent hazards in the laboratory are relatively
well defined, especially in the case of conventional disease-producing
agents. Major exceptions to this general observation are oncogenic agents
and "slow virus" infections.
Broadly speaking, two major risk situations can be identified.
In the first, known agents are used and are integral to scientific research
or teaching; in the second, potentially harmful biological agents are
endogenous to humans or laboratory animals or to animal tissues or fluids.
Examples of these are zoonotic infections harbored in the research animal
population, viral contaminants in human tissues and cell cultures, and
lymphocytic or choriomeningitis-infected animal tumor lines.
Other issues that do not relate specifically to personal
safety but should be considered include work with agents that infect lower
animals and plants, especially if an accident could seriously jeopardize
the agricultural sector of the economy. The possibility of cross-contamination
by infectious agents in laboratory animals and media preparation areas
can also be a significant problem, especially in common resource facilities.
See Table 7.4 for a list of agents
that have summary statements available from ORS.
7.2 Responsibilities
7.2.1 General. The
responsibilities of the department head, principal investigator, and others
working with biological hazards include all those described in Section
2.0 of this document. Additional responsibilities specific to the handling
of biological agents include selecting safety practices based on awareness
of the particular hazard and training all personnel accordingly.
7.2.2 Laboratory Safety Profile. Investigators shall submit
a Laboratory Safety Profile to ORS and/or the Chemical and Biological Safety
Committee for research involving biological agents that require containment
at Biosafety Level 2 or above. Investigators shall comply with the requirements
for each level of containment based on the biological agents used in research
projects. ORS can assist in determining the biosafety level of an agent.
The classification of the biosafety level is subject to the approval of
the CBSC. An investigator shall also submit an RDNA Registration form within ISIS for research
involving human materials and recombinant DNA.
7.3 Containment Methods
The term containment is used to describe safe methods for managing
infectious agents in the laboratory environment. The purpose of containment
is to reduce exposure of laboratory workers and others to potentially
hazardous agents and to prevent their escape into the outside environment.
The three elements of containment are laboratory practice and technique,
safety equipment, and facility design.
7.3.1 Laboratory Practice.
The most important element of containment is strict adherence to standard
microbiological practices and techniques. Persons working with infectious
agents or infected materials shall be aware of potential hazards and
shall be trained and proficient in the practices and techniques required
for safely handling such material. When standard laboratory practices
are not sufficient to control the hazard associated with a particular
agent or laboratory procedure, additional measures may be needed involving
safety equipment and facility design.
7.3.2 Safety Equipment (Primary Barriers).
Safety equipment includes biological safety cabinets, enclosed containers,
and other engineering controls designed to prevent or minimize exposures
to hazardous biological materials. The use of vaccines may in some cases
provide an increased level of personal protection.
7.3.2.1 Biological Safety
Cabinets (BSCs) The biological safety cabinet is the principal
device used to provide containment of infectious splashes or aerosols.
There are three types of biological safety cabinets: Class I, Class
II, and Class III.
Class I is an open-fronted, negative-pressure,
vented cabinet with HEPA-filtered exhaust. It may be equipped with
a front closure and gloves for use as a glove box. The inward face
velocity is a minimum of 75 linear feet per minute. Suitable for work
with low- or moderate-risk biological agents, it provides protection
for personnel and the environment but not for the product.
Class II cabinets are open-fronted laminar-flow
cabinets with a minimum inward face velocity of 75 linear feet per
minute. Class II design resembles that of a fume hood but with HEPA-filtered,
recirculated mass airflow within the workspace. Exhaust air is also
filtered. Class II cabinets provide protection for personnel, product,
and the environment. They are designed for work with low- or moderate-risk
biological agents.
Class III cabinets provide the highest level
of protection. Class III is a totally enclosed glove-box cabinet of
gas-tight construction. The cabinet is maintained under negative air
pressure of at least 0.5 inches of water gauge. Supply air is drawn
into the cabinet through HEPA filters, and the exhaust air is filtered
by two HEPA filters in series before it is discharged to the outside.
Generally, the ventilation system is separate from the facility's
ventilation system. Class III cabinets are suitable for high-risk
biological agents.
Biological safety cabinets used to protect workers
from hazardous biological agents shall be tested and certified after
installation and before use, any time they are moved, and at least
annually. The department head shall provide annual certification and
maintain certification records for the department. Testing shall meet
the criteria in National Sanitation Foundation Standard Number 49.
The biological safety cabinet shall be decontaminated prior to certification
or performance tests. See "Decontamination of Biological Safety
Cabinets" at http://www.research.northwestern.edu/ors/biosafe/parafrm2.htm.
Call ORS for information on the standard and a list of companies qualified
to certify biological safety cabinets.
For more detailed information about BSCs, refer to
the 1995 CDC/NIH publication "Primary Containment for Biohazards:
Selection, Installation and Use of Biological Safety Cabinets."
It can be found at http://www.cdc.gov/od/ohs/biosfty/bsc/bsc.htm.
7.3.2.2 Other Safety Equipment
Other safety equipment includes enclosed containers. An example of an
enclosed container is the safety centrifuge cap, designed to prevent
release of aerosols during centrifugation.
Safety equipment also includes personal protective
clothing and equipment such as gloves, coats, gowns, shoe covers,
boots, respirators, face masks or shields, and safety glasses or goggles.
This clothing and equipment is generally used in combination with
biological safety cabinets and other devices that contain the agents,
animals, or materials in use.
In situations in which it is impractical to work in
biological safety cabinets, personal protective devices may form the
primary barrier between personnel and the infectious materials. Examples
of such situations include certain animal studies, animal necropsy,
and activities relating to maintenance, service, or support of the
laboratory facility.
7.3.3 Facility Design (Secondary
Barriers). Secondary barriers protect the environment within the
facility but outside the laboratory-and the community outside the facility-from
exposure to infectious materials. The design of the facility provides
the secondary barrier. The three facility designs are the basic laboratory,
the containment laboratory, and the maximum containment laboratory.
The Basic Laboratory provides general space where
work is done with viable agents that are not associated with disease
in healthy adults; it includes Biosafety Levels 1 and 2 facilities.
This laboratory is also appropriate for work with infectious agents
or potentially infectious materials when the hazard levels are low and
laboratory personnel can be adequately protected by standard laboratory
practice. While work is commonly conducted on the open bench, certain
operations are confined to biological safety cabinets. Conventional
laboratory designs are adequate.
The Containment Laboratory has special engineering
features that enable laboratory workers to handle hazardous materials
without endangering themselves, the community, or the environment. The
containment laboratory is described as a Biosafety Level 3 facility.
The features that distinguish this laboratory from the basic laboratory
are the provisions for access control and a specialized ventilation
system. In all cases, a controlled access zone separates the laboratory
from areas open to the public.
The Maximum Containment Laboratory has special
engineering and containment features that allow laboratory workers to
safely conduct activities involving infectious agents that are extremely
hazardous to humans or capable of causing serious epidemic disease.
The maximum containment laboratory is described as a Biosafety Level
4 facility; it is not applicable to activities at the University.
7.4 Biosafety Levels
The following guidelines are recommended by the Centers for Disease
Control and Prevention and the National Institutes of Health and have
been adopted as required procedure at the University. They are drawn from
the book Biosafety in Microbiological and Biomedical Laboratories.
7.4.1 Biosafety Level 1.
Biosafety Level 1 (BSL-1) is suitable for work involving agents of no
known or minimal potential hazard to laboratory personnel and the environment.
The laboratory may be integral to general traffic patterns in the building.
Work may be conducted on open bench tops. Special containment equipment
is neither required nor generally used. Laboratory personnel shall have
specific training in procedures conducted in the laboratory.
7.4.1.1 Standard
Microbiological Practices for BSL-1
- At the discretion of the principal investigator,
access to the laboratory shall be limited or restricted while experiments
are in progress.
- A biohazard sign shall be posted at the entrance
to the laboratory whenever infectious agents are present. The sign
must include the name of the agent(s) in use and the name and phone
number of the principal investigator.
- Work surfaces shall be decontaminated once a day
and after any spill of viable material.
- All contaminated liquid or solid wastes shall
be decontaminated before disposal. Contaminated materials that are
to be decontaminated at a site outside the laboratory shall be placed
in a durable, leakproof, closed container before being removed from
the laboratory.
- The laboratory shall have an established policy
for the safe handling of sharps.
- Mechanical pipetting devices shall be used; mouth
pipetting is prohibited.
- Eating, drinking, smoking, and applying cosmetics
are not permitted in the work area. Food may be stored in cabinets
and refrigerators designated and used for this purpose only. Food
storage cabinets and refrigerators shall be located outside the
work area.
- Laboratory personnel shall wash their hands after
they handle viable materials and animals and before leaving the
laboratory.
- All procedures shall be performed carefully to
minimize the creation of aerosols.
- An insect and rodent control program is in effect.
At Northwestern, Facilities Management is responsible for the control
of pests and should be contacted if insects or rodents not involved
in research, or their wastes, are observed in the laboratory.
7.4.1.2 Safety Equipment for
BSL-1
- Special containment equipment is generally not
required for manipulation of agents assigned to Biosafety Level
1.
- It is recommended that laboratory coats, gowns,
or uniforms be worn to prevent contamination or soiling of street
clothes.
- Gloves should be worn if skin is broken or afflicted
by a rash.
7.4.1.3 Laboratory Facilities
for BSL-1
- The laboratory shall be designed so that it can
be easily cleaned.
- Bench tops shall be impervious to water and resistant
to acids, alkalis, organic solvents, and moderate heat.
- Laboratory furniture shall be sturdy. Spaces between
benches, cabinets, and equipment shall be accessible for cleaning.
- Each laboratory shall contain a sink for handwashing.
- If the laboratory has windows that open, they
shall be fitted with fly screens.
7.4.2 Biosafety Level 2. Biosafety
Level 2 is similar to Level 1 and is suitable for work involving agents
of moderate potential hazard to personnel and the environment. It differs
in that (1) laboratory personnel are specifically trained to handle pathogenic
agents and are directed by scientists who are experienced in working with
these agents, (2) access to the laboratory is limited when work is being
conducted, (3) extreme precautions are taken with contaminated sharp items,
and (4) certain procedures that may result in the creation of infectious
aerosols or splashes are conducted in biological safety cabinets or other
physical containment equipment.
The following standard and special practices, safety
equipment, and facilities apply to agents assigned to Biosafety Level
2.
7.4.2.1 Standard
Microbiological Practices for BSL-2
- At the discretion of the laboratory director,
access to the laboratory is limited or restricted while experiments
are in progress.
- Laboratory personnel are to wash their hands after
they handle viable materials and animals, after removing gloves,
and before leaving the laboratory.
- Eating, drinking, smoking, handling contact lenses,
and applying cosmetics are not permitted in the work areas. Food
is stored outside the work area in cabinets or refrigerators designated
and used for this purpose only.
- The laboratory shall have an established policy
for the safe handling of sharps.
- Mouth pipetting is prohibited; mechanical pipetting
devices are used.
- All procedures are performed carefully to minimize
the creation of splashes or aerosols.
- Work surfaces are decontaminated at least once
a day and after any spill of viable material.
- All cultures, stocks, and other regulated wastes
are decontaminated by an approved decontamination method, such as
autoclaving before disposal. Materials to be decontaminated outside
the immediate laboratory are to be placed in a durable, leakproof
container that is closed for transport from the laboratory.
- An insect and rodent control program is in effect.
At Northwestern, Facilities Management is responsible for the control
of pests and should be contacted if insects or rodents not involved
in research, or their wastes, are observed in the laboratory.
7.4.2.2 Special Practices for
BSL-2
- Access to the laboratory is limited or restricted
by the principal investigator when work with infectious agents is
in progress. In general, persons at increased risk of acquiring
infection or for whom infection may be unusually hazardous are not
allowed in the laboratory or animal rooms. Persons who are immunocompromised
or immunosuppressed may be at unusual risk of acquiring infections.
- The principal investigator establishes policies
and procedures whereby only persons who have been advised of the
potential hazard and meet specific requirements (e.g., immunization)
enter the laboratory or animal rooms.
- When an infectious agent requires special provisions
(e.g., immunization) for entering a laboratory where it is in use,
a hazard warning sign incorporating the universal biohazard symbol
is posted on the access door to the laboratory work area. The hazard
warning sign identifies the infectious agent, lists the name and
telephone number of the principal investigator or other responsible
person, and indicates the special requirements for entering the
laboratory.
- Laboratory personnel receive appropriate immunizations
for the agents handled or potentially present in the laboratory.
- When appropriate, baseline serum samples for laboratory
and other at-risk personnel are collected and stored. Additional
specimens may be collected periodically.
- A biosafety manual shall be developed for the
laboratory. Laboratory personnel are advised of special hazards
and are required to read and follow instructions on practices and
procedures.
- Laboratory personnel receive appropriate training
on the potential hazards associated with the work involved, the
necessary precautions to prevent exposures, and the exposure evaluation
procedures. Personnel receive annual retraining and receive additional
training when procedures or policies change.
- A high degree of precaution must always be taken
with any contaminated sharp items, including needles and syringes,
slides, pipettes, capillary tubes, and scalpels. Needles and syringes
should be used in the laboratory only when there is no alternative,
such as when parenteral injection, phlebotomy, or aspiration of
fluids from laboratory animals and diaphragm bottles are conducted.
Plasticware should be substituted for glassware whenever possible.
- Only needle-locking syringes or disposable
syringe-needle units (i.e., the needle is integral to the syringe)
are used for injection or aspiration of infectious materials.
Used disposable needles must not be bent, sheared, broken, recapped,
removed from disposable syringes, or otherwise manipulated by
hand before disposal; rather they must be carefully placed in
conveniently located puncture-resistant containers used for
sharps disposal. Nondisposable sharps must be placed in a hard-walled
container for transport to a processing area for decontamination,
preferably by autoclaving.
- Syringes that resheathe the needle, needleless
systems, and other safe devices should be used when appropriate.
- Broken glassware must not be handled directly
by hand but must be removed by mechanical means such as a brush
and dustpan, tongs, or forceps. Containers of contaminated needles,
sharp equipment, and broken glass are decontaminated before
disposal.
- Cultures, tissues, and specimens of body fluids
are placed in a container that prevents leakage during collection,
handling, processing, storage, transport, or shipping.
- Laboratory equipment and work surfaces should
be decontaminated with an appropriate disinfectant on a routine
basis as well as after work with infectious material is finished
and, especially, after overt spills, splashes, or other contamination
by infectious materials. Contaminated equipment must be decontaminated
before it is sent for repair or maintenance or packaged for transport.
- Spills or accidents that result in overt exposures
to infectious materials are immediately reported to the laboratory
director. Medical evaluation, surveillance, and treatment are provided
as appropriate at no cost to employees, and written records are
maintained.
- Animals not involved in the work being performed
are not permitted in the lab.
7.4.2.3 Safety Equipment for
BSL-2
- Properly maintained biological safety cabinets,
preferably Class II, or other appropriate personal protective equipment
or physical containment devices are used whenever:
- Procedures with a potential for creating infectious
aerosols or splashes are conducted. These may include centrifuging,
grinding, blending, vigorous shaking or mixing, sonic disruption,
opening containers of infectious materials in which internal
pressure may differ from ambient pressure, inoculating animals
intranasally, and harvesting infected tissues from animals or
eggs.
- High concentrations or large volumes of infectious
agents are used. Such materials may be centrifuged in the open
laboratory if sealed rotor heads or centrifuge safety cups are
used and if these rotors or safety cups are opened only in a
biological safety cabinet.
- Face protection (goggles, mask, face shield, or
other splatter guards) is used for anticipated splashes or sprays
of infectious or other hazardous materials to the face when the
microorganisms must be manipulated outside the biological safety
cabinet.
- Protective laboratory coats, gowns, smocks, or
uniforms designated for lab use are worn in the laboratory. This
protective clothing is removed and left in the laboratory before
lab personnel leave for nonlaboratory areas (e.g., cafeteria, library,
or offices). All protective clothing is either disposed of in the
laboratory or sent to the laundry service (only after being decontaminated).
It is never taken home.
- Lab personnel wear gloves when handling infected
animals and when hands may come in contact with infectious materials
or contaminated surfaces or equipment. Wearing two pairs of gloves
may be appropriate; if a spill or splatter occurs, the hand will
be protected after the contaminated glove is removed. Gloves are
disposed of when contaminated, removed when work with infectious
materials is completed, and not worn outside the laboratory. Disposable
gloves are not washed or reused.
7.4.2.4 Laboratory Facilities
(Secondary Barriers) for BSL-2
- Provide lockable doors for facilities that house
restricted agents (see Table 7.1).
- Each laboratory contains a sink for handwashing.
- The laboratory is designed so that it can be easily
cleaned. Rugs are not appropriate in laboratories.
- Bench tops are impervious to water and resistant
to acids, alkalis, organic solvents, and moderate heat.
- Laboratory furniture is sturdy, and spaces between
benches, cabinets, and equipment are accessible for cleaning.
- If the laboratory has windows that open, they
are fitted with fly screens.
- An eyewash facility is readily available.
- Biological safety cabinets shall be installed
in such a manner that fluctuations of the room supply and exhaust
air do not cause them to operate outside their parameters for containment.
Biological safety cabinets shall be located away from doors, from
windows that can be opened, from heavily traveled laboratory areas,
and from other potentially disruptive equipment so as to maintain
the biological safety cabinets' air flow parameters for containment.
- Illumination shall be adequate for all activities,
avoiding reflections and glare that could impede vision.
7.4.3 Biosafety Level 3.
All work to be conducted with agents assigned to Biosafety Level 3 must
be approved in advance by the Chemical and Biological Safety Committee.
If you desire to work with BSL-3 agents, contact ORS in advance.
BSL-3 work must be conducted in accordance with the
facility safeguards, standard microbiological practices, special practices,
and safety equipment described in Biosafety in Microbiological and
Biomedical Laboratories. See Tables 7.7
and 7.8 for lists of biohazardous agents that
must be handled at BSL-3.
Biosafety Level 3 is applicable to clinical, diagnostic,
teaching, research, or production facilities in which work is done with
indigenous or exotic agents that may cause serious or potentially lethal
disease as a result of exposure by inhalation. Laboratory personnel
have specific training in handling pathogenic and potentially lethal
agents and are supervised by scientists experienced in working with
these agents.
All procedures involving the manipulation of infectious
materials are conducted within biological safety cabinets or other physical
containment devices, or by personnel wearing appropriate personal protective
clothing and equipment. The laboratory has special engineering and design
features such as access zones, sealed penetrations, and directional
airflow.
Many laboratories may not have all the facility safeguards
recommended for Biosafety Level 3. In these circumstances, acceptable
safety may be achieved for routine or repetitive operations (e.g., diagnostic
procedures involving the propagation of an agent for identification,
typing, and susceptibility testing) in Biosafety Level 2 facilities.
However, the recommended standard microbiological practices, special
practices, and safety equipment for Biosafety Level 3 must be rigorously
followed.
7.4.4 Biosafety Level 4. University
use of biological agents requiring Biosafety Level 4 containment practices
is not anticipated. Should an investigator wish to conduct research with
these agents, a specially developed Laboratory Safety Profile shall be submitted
to the Chemical and Biological Safety Committee for review and approval
prior to initiation of research. Approval is also required by the vice
president for research prior to initiation of research.
7.5 Biological Spills
A biological spill shall be followed by prompt action to contain and
clean up the spill. When a spill occurs, warn everyone in the area and
call for assistance as needed. The degree of risk involved in the spill
depends on the volume of material spilled, the potential concentration
of organisms in the material spilled, the hazard of the organisms involved,
the route of infection of the organisms, and the diseases caused by the
organisms.
Spills of biological agents can contaminate areas and
lead to infection of laboratory workers. Prevention of exposure is the
primary goal in spill containment and cleanup, exactly as in chemical
spills. In evaluating the risks of spill response, generation of aerosols
or droplets is a major consideration.
If an accident generates droplets or aerosols in the laboratory
room atmosphere, especially if the agent involved requires containment
at Biosafety Level 2 or higher, the room shall be evacuated immediately.
Doors shall be closed and clothing decontaminated. Call
ORS to supervise the cleanup. In general, a 30-minute wait is sufficient
for the droplets to settle and aerosols to be reduced by air changes.
Longer waiting periods may be imposed depending on the situation. Laboratory
personnel and/or ORS must exercise judgment as to the need for outside
emergency help in evacuation.
If a spill of a biological agent requiring containment
at Biosafety Level 2 or higher occurs in a public area, evacuation of
the area shall be immediate. The principal investigator shall be responsible
for designating the extent of evacuation until ORS or emergency personnel
arrive. Prevention of exposure to hazardous aerosols is of primary importance.
Anyone cleaning a spill shall wear personal protective
equipment (for example, laboratory coat, shoe covers, gloves, and possible
respiratory protection) to prevent exposure to organisms. An air-purifying
negative-pressure respirator with P-100 filter cartridges is generally
adequate protection against inhalation of most biological agents. However,
there may be exceptions. Contact ORS for advice in choosing the correct
respiratory protection and for information regarding the requirements
that must be met to wear a respirator.
An appropriate chemical disinfectant should be chosen
that is effective against the organisms involved in the spill (see Tables
7.3A and 7.3B).
7.5.1 Sterilization, Disinfection,
and Decontamination. The Environmental Protection Agency recognizes
the following categories of chemical germicides (a germicide is an agent
that kills pathogenic organisms). The information in this section is
drawn from Protection of Laboratory Workers from Instrument Biohazards
and Infectious Disease Transmitted by Blood, Body Fluids, and Tissue,
Approved Guideline, NCCLS Document M29-A, Vol. 17, No.20 (National Committee
for Clinical Laboratory Standards, December, 1997).
Sterilizer or Sterilant: An agent intended
to destroy all microorganisms and their spores on inanimate surfaces.
Disinfectant: An agent intended to destroy or
irreversibly inactivate specific viruses, bacteria, or pathogenic fungi,
but not necessarily their spores, on inanimate surfaces. Most disinfectants
are not effective sterilizers.
Hospital Disinfectant: An agent shown to be effective
against specific organisms such as Staphylococcus aureus, Salmonella
choleraesuis, and Pseudomonas aeruginosa. It may also be
effective against other organisms and some viruses. The labels of all
commercially available hospital disinfectants contain a claim (which
must be documented) of effectiveness for specific agents.
Antiseptic: A chemical germicide formulated for
use on skin or tissue. Antiseptics should not be used as disinfectants.
Decontamination: A procedure that eliminates
or reduces microbial contamination to a safe level with respect to the
transmission of infection. Sterilization and disinfection procedures
are often used for decontamination.
The OSHA Bloodborne Pathogens Standard requires that
all equipment and environmental and working surfaces shall be cleaned
and decontaminated after contact with blood or other potentially infectious
materials. The standard also requires decontamination of contaminated
work surfaces after completion of procedures, immediately or as soon
as feasible after any overt contamination of surfaces or any spill of
potentially infectious material, and at the end of the work shift if
the work surface has become contaminated. All reusable equipment shall
be decontaminated immediately or as soon as feasible upon visible contamination.
It should be emphasized that, for any infectious material,
adequate precleaning of surfaces is important for any disinfection or
sterilization procedure. Ten minutes of exposure to a disinfectant may
not be adequate to disinfect objects that have narrow channels or other
areas that can harbor microorganisms. Alcohols, for example,
are effective for killing hepatitis B virus (HBV) but are not recommended
for this purpose because of their rapid evaporation and the consequent
difficulty of maintaining proper contact times.
Chlorine compounds are probably the most widely
used disinfectants in the laboratory. You can easily prepare an inexpensive,
broad-spectrum disinfectant by diluting common household bleach.
Bleach is a 5.25% sodium hypochlorite solution-this
is equal to approximately 50,000 ppm of free available chlorine. This
level of chlorine can be harmful to skin and eyes. Lower concentrations
are effective in disinfection and are less hazardous for the worker.
The concentration to be used is based on your assessment of the severity
of the contamination or spill of infectious materials.
- For small spills of infectious agents or for contamination
on hard, smooth surfaces, a 1:100 dilution of commercial bleach is
adequate. This is equivalent to 500 ppm of free chlorine.
- In the case of large or concentrated spills of infectious
agents, a higher level of chlorine is needed to be effective in destroying
the microorganisms. Use a 1:10 dilution (5,000 ppm of free chlorine)
and flood the contaminated area with the solution. Alternatively,
you can mix the disinfectant with the spilled material. This higher
concentration is more suitable for porous surfaces that may harbor
organisms in tiny cracks or pits.
Make the solution fresh each day. Be aware that chlorine
compounds may corrode metals, especially aluminum. While a 10% household
bleach solution is a commonly used decontaminant concentration, it is
probably stronger than necessary for ordinary uses. It can be extremely
irritating to personnel. Therefore, the use of higher concentrations
of bleach in chemical fume hoods, and the autoclaving of materials that
have been treated with bleach, should be reserved for significant contamination.
Note that bleach will react with water to form hypochlorous
acid (HOCl), which will decompose to chlorine (Cl2) and hydrogen
chloride (HCl). Special care should be taken when autoclaving hypochlorite
solutions because the procedure can generate chlorine gas, which will
corrode steel. To avoid evolution of chlorine, the hypochlorite solution
should be neutralized with sodium thiosulfate prior to autoclaving.
Formaldehyde is an OSHA-regulated chemical that
is a suspect carcinogen, so its use as a disinfectant is not recommended.
Iodophors that are registered with the EPA may
be effective hard-surface decontaminants when used per manufacturer's
instructions, but iodophors formulated as antiseptics are not suitable
for use as disinfectants.
Peracetic (peroxyacetic) acid and hydrogen peroxide
mixtures minimize the negative effects of corrosiveness sometimes seen
with chlorine compounds and high concentrations of peracetic acid alone.
A limited number of trade-name products containing <0.1% peracetic acid
and <1.0% hydrogen peroxide and registered with the EPA as sterilants/disinfectants
are available. The benefit of these products is their rapid action and
broad-spectrum of germicidal activity, in addition to the reduced corrosiveness.
In Section 5.0, the use of any chemicals with the prefix
"per" is discouraged for cleaning glassware due to the reactivity
of oxidizing materials. Peracetic acid is generally a strong irritant.
The low percentage in these products reduces this danger. Nonetheless,
these products are intended only for highly concentrated spills of biological
materials.
Quaternary ammonium compounds are low-level disinfectants
and are not recommended for spills of human blood, blood products, or
other potentially infectious materials.
7.5.2 Decontamination of Spills.
The following procedure is recommended for decontaminating spills of agents
used at BSL-2.
- Wear gloves and a laboratory coat or gown. Heavyweight,
puncture-resistant utility gloves, such as those used for housecleaning
and dishwashing, are recommended.
- Do not handle sharps with the hands. Clean up broken
glass or other sharp objects with sheets of cardboard or other rigid,
disposable material. If a broom and dustpan are used, they must be
decontaminated later.
- Avoid generating aerosols by sweeping.
- Absorb the spill. Most disinfectants are less effective
in the presence of high concentrations of protein, so absorb the bulk
of the liquid before applying disinfectants. Use disposable absorbent
material such as paper towels. After absorption of the liquid, dispose
of all contaminated materials as waste.
- Clean the spill site of all visible spilled material
using an aqueous detergent solution (e.g., any household detergent).
Absorb the bulk of the liquid to prevent dilution of the disinfectant.
- Disinfect the spill site using an appropriate disinfectant,
such as a household bleach solution. Flood the spill site or wipe
it down with disposable towels soaked in the disinfectant.
- Absorb the disinfectant or allow it to dry.
- Rinse the spill site with water.
- Dispose of all contaminated materials properly.
Place them in a biohazard bag or other leakproof, labeled biohazard
container for sterilization.
7.5.3 Biological Spill in the
Open Laboratory. For a spill in the open laboratory outside a biological
safety cabinet, the spill response depends on the size of the spill
and hazard of the material. A minimally hazardous material spilled without
generating appreciable aerosols can be cleaned with a paper towel soaked
in a chemical disinfectant.
A spill of a larger volume of hazardous material with
aerosol generation requires evacuating the room, waiting for aerosol
reduction, donning personal protective gear (including appropriate respiratory
protection), selecting a disinfectant effective against the organisms
involved, and cleaning as described above. Following cleanup, response
personnel shall wash or shower with a disinfectant soap.
7.5.4 Biological Spill Within
a Biological Safety Cabinet. A spill that is confined within a biological
safety cabinet generally presents little or no hazard to personnel in
the area. However, chemical disinfection procedures are to be initiated
at once while the cabinet continues to operate. The disinfectant shall
be one that is active against the organisms of potential hazard. Flammable
liquids, such as ethanol or isopropanol, shall not be used, even if
effective, because of the fire hazard of generating dangerous vapor
concentrations within the cabinet that could be ignited by an electrical
spark or other source.
Spray or wipe the walls, work surfaces, and equipment
with the chosen disinfectant. Allow the disinfectant to remain on the
surface for the appropriate contact time (refer to Table
7.3A and 7.3B for recommended contact times).
Minimize the generation of aerosols and use sufficient
disinfectant to ensure that drain pans and catch basins below the work
surface contain disinfectant. The front exhaust shall also be wiped
and the disinfectant drained into a container.
7.5.5 Biological Spill in a Centrifuge
or Other Equipment. A biological spill in a centrifuge has the potential
for producing large volumes of aerosols. On becoming aware that a spill
may have occurred within a centrifuge or other piece of equipment, turn
off the equipment, warn others in the area, notify the principal investigator,
allow aerosols to settle, and decontaminate following the principles
described above.
7.5.6 Biological Spill on a Person.
If a biological material is spilled on a person, emergency response
is based on the hazard of the biological agent spilled, the amount of
material spilled, and whether significant aerosols were generated. If
aerosol formation is believed to have been associated with the spill,
a contaminated person shall leave the contaminated area immediately.
If possible, (s)he should go to another laboratory area so that hallways
and other public areas do not become contaminated.
Contaminated clothing is removed and placed in red or
orange biohazard bags for disinfecting. Contaminated skin shall be flushed
with water and thoroughly washed with a disinfectant soap. Showering
may be appropriate, depending on the extent of the spill.
7.6 Human Blood, Blood Products,
and Other Potentially Infectious Materials
Northwestern University is required to comply with the
OSHA Occupational Exposure to Bloodborne Pathogens Standard found in Title
29, Code of Federal Regulations, Part 1910.1030. The requirements of the
standard are covered in the Bloodborne Pathogens Program. This
document is available from ORS or on the Web at http://www.research.northwestern.edu/ors/biosafe/index.htm.
You should refer to the Bloodborne Pathogens Program
if your work requires occupational exposure to any of the following human
materials:
- Blood (human blood, human blood components, and products
made from human blood)
- These human body fluids:
semen
vaginal secretions
cerebrospinal fluid
synovial fluid
pleural fluid
pericardial fluid
peritoneal fluid
amniotic fluid
saliva (in dental procedures)
any body fluid that is visibly contaminated with blood
all body fluids in situations where it is difficult or impossible to
differentiate between body fluids
- Any unfixed tissue or organ (other than intact skin)
from a human, living or dead.
- HIV-containing cell, tissue, or organ cultures; HIV-
or HBV-containing culture medium or other solutions; and blood, organs,
or other tissues from experimental animals infected with HIV or HBV.
Occupational exposure means reasonably anticipated skin,
eye, mucous membrane, or parenteral contact with blood or other potentially
infectious materials that may result from the performance of an employee's
duties.
7.7 Recombinant DNA Research
Recombinant DNA research shall comply with the National Institutes
of Health's "Guidelines for Research Involving Recombinant DNA Molecules,"
as published in the Federal Register, July 5, 1994, Volume 59, No. 127,
pages 34,496 through 34,547, and any subsequent amendments thereto. The
Recombinant DNA Safety Committee is responsible for implementing the guidelines
and overseeing recombinant DNA research.
Principal investigators intending to use recombinant DNA
molecules shall follow the directions in the University's Recombinant
DNA Safety Program, available from ORS or on the Web at http://www.research.northwestern.edu/ors/biosafe/index.htm.
All recombinant DNA research falls into one of six classes, described
in the NIH guidelines as follows:
- Section III-A Experiments that require Institutional
Biosafety Committee approval, Recombinant DNA Advisory Committee (RAC)
review, and NIH Director approval before initiation
- Section III-B Experiments that require NIH/ORDA and
Institutional Biosafety Committee approval before initiation
- Section III-C Experiments that require Institutional
Biosafety Committee and Institutional Review Board approval and NIH/ORDA
registration before initiation
- Section III-D Experiments that require Institutional
Biosafety Committee approval before initiation
- Section III-E Experiments that require Institutional
Biosafety Committee notice simultaneous with initiation
- Section III-F Exempt experiments
If an experiment falls into section III-A, III-B, or III-C
and one of the other sections as well, the rules pertaining to section
III-A, III-B, or III-C shall be followed. If an experiment falls into
section III-F alone, or into section III-F and into section III-D or III-E
as well, the experiment is considered exempt from the NIH guidelines.
In general, the containment practices to be used for recombinant
DNA research shall follow those described for Biosafety Levels 1, 2, and
3 in the CDC-NIH Biosafety in Microbiological and Biomedical Laboratories.
However, the NIH Recombinant DNA guidelines take precedence.
7.8 Animal Studies
Animal studies involving the use of hazardous biological agents represent
special problems in containment. Policies and operational practices governing
the use of animal containment facilities are under the direction of the
Animal Care and Use Committee and the Center for Experimental Animal Resources.
In general, practices for Animal Biosafety Levels 1, 2, and 3 presented
in the CDC-NIH manual, Biosafety in Microbiological and Biomedical
Laboratories, are followed.
Experiments involving the use of infectious biological
agents in animals are generally conducted in containment facilities. Research
in laboratory facilities shall be reviewed and approved, prior to the
initiation of work, by the CBSC in conjunction with the Animal Care and
Use Committee and the Center for Experimental Animal Resources.
7.9 Handling of Sheep Cells
The University has adopted special policies for the handling of sheep
cells due to the potential risk associated with Q fever.
All potentially infectious sheep cells shall be handled
at BSL-2, similar to requirements for human cell cultures (as written
in the Laboratory Safety Profile).
Lab workers shall assume that all sheep cells are infectious
unless there is acceptable serologic confirmation that they are not. Where
vendors offer verification of testing of cells before shipment, the following
criterion must be met: a biological safety professional or other qualified
scientist with background and experience to review potential contamination
and risk shall comment, in writing, on the test methods and molecular
technology applied to a cell line sample to identify or screen for infectivity.
BSL-3 practices shall be applied in handling cells from
sheep birth products (e.g., amniotic fluid, placenta).
7.10 Importation or Transport Permits
The US Department of Agriculture (USDA), Animal and Plant Health Inspection
Service (APHIS), Veterinary Services (VS), regulates
- the importation of all animal-origin materials
(animal products and byproducts) that could present a disease risk to
US livestock
- the import and transport of infectious organisms and
vectors of disease agents
- biological materials that contain or have been in contact
with certain organisms and animal materials (including cell cultures).
Generally, an USDA veterinary permit is needed for materials
derived from animals or exposed to animal-source materials. Materials
which require a permit include animal tissues, blood, cells or cell lines
of livestock or poultry origin, RNA/DNA extracts, hormones, enzymes, monoclonal
antibodies for IN VIVO use in non-human species, certain polyclonal antibodies,
antisera, bulk shipments of test kit reagents, and microorganisms including
bacteria, viruses, protozoa, and fungi. Exceptions to this requirement
are human and nonhuman primate tissues, serum, and blood.
Permit applications are available through the Web (http://www.aphis.usda.gov/animal_health/permits/)
or the local USDA port office in Des Plaines, IL. The phone number is
(847) 298-5220. Alternatively, you may call the national import-export
products staff at (301) 734-7885 for further information.
There are certain materials (listed below) allowed to
be imported without an USDA permit; however, USDA inspectors will nonetheless
review these materials at the port of entry. ORS maintains a copy of the
USDA "Guidelines for Importation" on file for a discussion of
the necessary shipping documents that must accompany the materials. These
particular guidelines (http://www.aphis.usda.gov/NCIE/fac_imp.html)
cover:
- Human and nonhuman primate material
Includes: tissues, blood, extracts, proteins, DNA, human vaccines
in final dosage form
- Feline and canine material
Includes: blood, tissues, serum, feces, extracts, fluids, canine
semen for research purposes
Does Not Include: cell cultures, tissue cultures, cell culture
products, canine semen for reproductive purposes
- Live laboratory mammals and their material-for research
purposes
Includes: transgenic/knock-out mice and rats, hamsters, gerbils,
guinea pigs, rabbits, and their blood, tissue, DNA, extracts, antibodies,
feces, sera, and antisera
Does Not Include: primates, dogs, cats, livestock*, poultry,
hedgehogs, tenrecs, monoclonal antibodies, hybridomas, cell lines, and
material for commercial purposes
- Amphibians, fish, reptiles, shellfish and aquatic species
Includes: blood, tissues, serum, feces, extracts, fluids, venom,
urine from these species
Does Not Include: antivenom
- Chemically synthesized materials
Includes: biochemicals, materials not containing or derived from
animal products
- Microbially produced materials
Includes: enzymes, plasmids, proteins, antibiotics, hormones,
extracts, phages, DNA
- Recombinant microbes and their products
Includes: microbes (bacteria, viruses, yeasts/fungi), proteins,
hormones, extracts, plasmids, DNA, RNA
Does Not Include: materials produced by cell culture techniques
- Nonpathogenic microorganisms (and their extracts)
Includes: environmental or water organisms, such as algae
- Cell cultures/lines, recombinant cell cultures/lines,
and their products (for IN VITRO use)
Includes: monoclonal antibodies, cell culture supernatants, ascitic
fluid, cell extracts, hybridomas, cell cultures/lines which are not
derived from livestock* or avian species
Does Not Include: cell lines of livestock* or avian species origin
and their products, microbial cultures and their products
- Test kits
Includes: pre-packaged kits and kit components (reagents, calibraters,
controls) packaged for final use
Does Not Include: kits used to diagnose infectious diseases of
animals (excluding humans)
*Livestock includes any bovine, ovine, caprine, porcine,
and equine animal.
7.11 Transfer of Select Agents
For current information on the University's Select Agents Program, please see http://www.research.northwestern.edu/ors/biosafe/selectagents.htm.
7.12 Infectious Waste Management
Infectious waste materials shall be treated properly to
eliminate the potential hazard that these wastes pose to human health
and the environment. Treatment commonly involves steam sterilization or
incineration.
7.12.1 Separation and Packaging
of Infectious Waste. Infectious wastes shall be separated from general,
noninfectious waste materials and from wastes containing radioactive,
carcinogenic, or toxic materials. Some wastes may contain multiple hazards.
These shall be handled such that priority is given to the greatest hazard
present. A procedure for handling mixed biological/radioactive waste
has been prepared by ORS and is available on request. It is also available
in the ORS publication Radiation
Safety Handbook(pdf).
Disposable infectious materials shall be placed in red
or orange plastic bags. The bags shall be seamless, tear-resistant,
and autoclavable. Single bags shall have a minimum thickness of 3.0
mils and double bags, 1.5 to 2.0 mils. Bags shall be closed by folding
or tying when full, at the end of the day, or before transporting.
To minimize formation of aerosols, infectious wastes
shall not be compacted prior to decontamination.
7.12.2 Storage and Transport
of Infectious Waste. Infectious wastes that are removed from a laboratory
or stored temporarily shall be closed and double-bagged or placed inside
a covered, unbreakable outer container.
7.12.3 Infectious Waste Treatment.
Infectious wastes are generally rendered noninfectious by autoclaving,
although incineration is occasionally used. After sterilization, previously
infectious wastes are disposed of as noninfectious. They may be placed
in noninfectious trash collection containers and sent to a sanitary
landfill. Treated wastes in red or orange bags shall be overpacked into
opaque plastic bags of another color (not yellow) for noninfectious
disposal. The custodial staff has been instructed not to touch or remove
red, orange, or yellow bags. Sterilized liquid wastes may be discarded
to the sewer.
As described under procedures for Biosafety Levels 2
and 3 and in the Bloodborne
Pathogens Program, syringes and needles shall be handled with
extreme caution to avoid autoinoculation and the generation of aerosols.
Needles shall not be bent, sheared, replaced in the sheath or guard,
or removed from the syringe following use. The needle and syringe shall
be promptly placed in a puncture-resistant container. Please contact ORS for further information regarding needle disposal.
All human blood, blood products, nonfixed human tissues,
and other potentially infectious materials are considered infectious
and shall be disinfected, steam sterilized, or incinerated. Sterilized
blood-related waste materials are discarded as nonhazardous.
Infectious wastes, including cultures and stocks of
etiologic agents, shall be made noninfectious by steam sterilization.
Sterilized wastes are disposed of as nonhazardous.
Pathological wastes are generally incinerated. Steam
sterilization is acceptable, although after sterilization, pathological
wastes shall be either incinerated or ground and flushed to a sewer.
Animal carcasses, bedding, and wastes are generally
incinerated as directed by the Center for Experimental Animal Resources.
7.12.3.1 Steam Sterilization
Most infectious wastes are sterilized, based on the
type of waste, load volume, packaging material, and load configuration.
It is recommended that the efficacy of the autoclave be monitored
using Bacillus stearothermophilis. The frequency of monitoring
depends on the hazard of the organism being used and the frequency
of waste sterilization.
Infectious wastes that also contain volatile chemicals
should be autoclaved only if a chemical (hydrophobic) filter is on
line. ORS shall be contacted before steam sterilizing wastes containing
carcinogens or radionuclides.
7.12.3.2 Incineration
Incineration is preferred for pathological and animal
wastes. At the University, incineration is handled by the Center for
Experimental Animal Resources. ORS may be contacted for additional
information.
7.12.3.3 Chemical Disinfection
Chemical treatment is usually a disinfection rather
than sterilization. Thus it is usually intended as a temporary measure
to control infectious wastes until sterilization can treat the hazard.
Disinfection may be used as final treatment on a case-by-case basis
following a petition by the principal investigator and approval by
the Chemical and Biological Safety Committee.
Section 7.5.1 and Tables 7.3A
and 7.3B summarize information on practical
disinfectants.
|
Table 7.3A Summary of
Practical Disinfectants
|
|
Disinfectant
|
Dilution
|
Contact
time (minutes)
|
Irritant
type
|
| |
|
Lipovirus
|
Broad-Spectrum
|
Skin
|
Eye
|
Respiratory
|
|
Quaternary ammonium cpds. (L)
|
0.1-2.0%
|
10
|
Not effective
|
Yes
|
Yes
|
No
|
|
Phenolic cpds. (L)
|
1.0-5.0%
|
10
|
Not effective
|
Yes
|
Yes
|
No
|
|
Chlorine cpds. (L)
|
500ppm*
|
10
|
30
|
Yes
|
Yes
|
Yes
|
|
Iodophor cpds. (L)
|
25-1600ppm
|
10
|
30
|
Yes
|
Yes
|
No
|
|
Ethyl alcohol (L)
|
70-85%
|
10
|
Not effective
|
No
|
Yes
|
No
|
|
Isopropyl alcohol (L)
|
70-85%
|
10
|
Not effective
|
No
|
Yes
|
No
|
|
Formaldehyde (L)
|
0.2-8.0%
|
10
|
30
|
Yes
|
Yes
|
No
|
|
Glutaraldehyde (L)
|
2%
|
10
|
30
|
Yes
|
Yes
|
No
|
|
Ethylene oxide (G)
|
8-23g/ft3
|
60
|
60
|
Yes
|
Yes
|
Yes
|
|
Paraformaldehyde (G)
|
0.3g/ft3
|
60
|
60
|
Yes
|
Yes
|
Yes
|
|
L = liquid; G = gas
|
|
*Commercially available chlorine bleach is 5.25%
chlorine (52,200 ppm). A dilution of 1 to 100 will yield a 525 ppm
solution, which is suitable for disinfecting purposes.
|
|
Source: Laboratory Safety Monograph, U.S.
Department of Health, Education, and Welfare, Public Health Servic,
and National Institutes of Health, 1979.
|
|
Table
7.3B Decontaminants and Their Use in Infectious Waste Management
|
|
|
Ethylene Oxide
|
Para-form-
aldehyde
(gas)
|
Quaternary Ammonium
Compounds
|
Phenolic Compounds
|
Chlorine Compounds
|
Iodophor Compounds
|
Alcohol (ethyl or
isopropyl)
|
Form
-aldehyde (liquid)
|
Glutar-
aldehyde
|
|
Use Parameters
|
|
Concen
-tration
of active ingredient
|
400-800mg/l
|
0.3g/ft3
|
0.1-2%
|
0.2-3%
|
0.01-5%
|
0.47%
|
70-85%
|
4-8%
|
2%
|
|
Temper
-ature
, ēC
|
35-60
|
>23
|
|
|
|
|
|
|
|
|
Relative humidity,
%
|
30-60
|
>60
|
|
|
|
|
|
|
|
|
Contact
time,
minutes
|
105-240
|
60-180
|
10-30
|
10-30
|
10-30
|
10-30
|
10-30
|
10-30
|
10-600
|
|
Effective Againsta
|
|
Vegetative bacteria
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
|
Bacterial spores
|
+
|
+
|
|
|
×
|
|
|
×
|
+
|
|
Lipo viruses
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
|
Hydrophilic viruses
|
+
|
+
|
|
×
|
+
|
×
|
×
|
+
|
+
|
|
Tubercl
bacilli
|
+
|
+
|
|
+
|
+
|
+
|
+
|
+
|
+
|
|
HIV
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
|
HBV
|
+
|
+
|
|
×
|
+
|
×
|
×
|
+
|
+
|
|
Applicationsa
|
|
Contam
-inated
liquid
discard
|
|
|
|
+
|
|
|
|
×
|
|
|
Contam
-inated glassware
|
×
|
|
+
|
+
|
+
|
+
|
|
×
|
+
|
|
Contam
-inated instruments
|
×
|
|
|
+
|
+
|
|
|
×
|
+
|
|
Equipmen
total
decontam
-ination
|
×
|
+
|
|
|
|
|
|
|
|
|
a + denotes
very positive response; ×, a less positive response; and a blank,
a negative response or not applicable.
|
|
Adapted from Laboratory
Safety, Principles and Practices, D. Fleming, J. Richardson,
J. Tulis, D. Vesley;
American Society for Microbiology, 1995: 226-227.
|
| Table 7.4 Agent
Summary Statements Available |
| The following agent summary statements
are available from ORS. Source: Biosafety in Microbiological and
Biomedical Laboratories, HHS Publication No. (CDC) 93-8395, CDC/NIH,
3rd edition, May 1999. |
|
Parasitic Agents
Blood and Tissue Protozoal Parasites of Humans
Intestinal Protozoal Parasites of Humans
Trematode Parasites of Humans
Cestode Parasites of Humans
Nematode Parasites of Humans
Fungal Agents
Blastomyces dermatitidis
Coccidioides immitis
Cryptococcus neoformans
Histoplasma capsulatum
Sporothrix schenckii
Pathogenic Members of the Genera Epidermophyton,
Microsporum, and Trichophyton
Miscellaneous Molds
Bacterial Agents
Bacillus anthracis
Bordetella pertussis
Brucella (B. abortus, B. canis, B. melitensis,
B. suis)
Burkholderia pseudomallei (Pseudomonas pseudomallei)
Campylobacter (C. jejuni/C. coli, C. fetus subsp.
fetus)
Chlamydia psittaci, C. pneumoniae, C. trachomatis
Clostridium botulinum
Clostridium tetani
Corynebacterium diphtheriae
Escherichia coli (Cytotoxin-producing (VTEC/SLT) organisms)
Francisella tularensis
Helicobacter pylori
Leptospira interrogans - all serovars
Listeria monocytogenes
Legionella pneumophila; other Legionella-like agents
Mycobacterium leprae
Mycobacterium spp. other than M. tuberculosis, M.
bovis or M. leprae
Mycobacterium tuberculosis, M. bovis
Neisseria gonorrhoeae
Neisseria meningitidis
Salmonella - all serotypes except typhi
Salmonella typhi
Shigella spp.
Treponema pallidum
Vibrionic enteritis (Vibrio cholerae, V. parahaemolyticus)
Yersinia pestis
|
Prions
Rickettsial Agents
Coxiella burnetii
Rickettsia prowazekii, Rickettsia typhi (R. mooseri),
Orientia (Rickettsia) tsutsugamushi and Spotted Fever
Group agents of human disease; Rickettsia rickettsii,
Rickettsia conorii, Rickettsia akari, Rickettsia
australis, Rickettsia siberica, and Rickettsia japonicum
Viral Agents (other than arboviruses)
Hantaviruses
Hendra and Hendra-like Viruses (includes virus formerly known as
Equine Morbillivirus)
Hepatitis A Virus, Hepatitis E Virus
Hepatitis B Virus, Hepatitis C Virus (formerly known as nonA nonB
Virus), Hepatitis D Virus
Herpesvirus simiae (Cercopithecine herpesvirus [CHV-1],
B-virus)
Human Herpesviruses
Influenza
Lymphocytic Choriomeningitis Virus
Poliovirus
Poxviruses
Rabies Virus
Retroviruses, including Human and Simian Immunodeficiency
Viruses (HIV and SIV)
Transmissible Spongiform Encephalopathies (Creutzfeldt-Jakob,
kuru and related agents)
Vesicular Stomatitis Virus
Arboviruses and Related Zoonotic Viruses -
see the following tables:
Table 7.5 Arboviruses and Arenaviruses
Assigned to Biosafety Level 2
Table 7.6 Vaccine Strains of
BSL-3/4 Viruses Which May be Handled at BSL-2
Table 7.7 Arboviruses and Certain
Other Viruses Assigned to BSL-3 (on the basis of insufficient experience)
Table 7.8 Arboviruses and Certain
Other Viruses Assigned to BSL-3
|
| Table
7.5 Arboviruses and Arenaviruses Assigned to Biosafety Level 2 |
|
Acado
|
Chandipura
|
Kamese
|
Murutucu
|
Sokuluk
|
|
Acara
|
Changuinola
|
Kammavanpettai
|
Mykines
|
Soldado
|
|
Aguacate
|
Charleville
|
Kannamangalam
|
Navarro
|
Sororoca
|
|
Alfuy
|
Chenuda
|
Kao Shuan
|
Nepuyo
|
Stratford
|
|
Almpiwar
|
Chilibre
|
Karimabad
|
Ngaingan
|
Sunday Canyon
|
|
Amapari
|
Chobar gorge
|
Karshi
|
Nique
|
Tacaiuma
|
|
Ananindeua
|
Clo Mor
|
Kasba
|
Nkolbisson
|
Tacaribe
|
|
Anhanga
|
Colorado tick fever
|
Kemerovo
|
Nola
|
Taggert
|
|
Anhembi
|
Corriparta
|
Kern Canyon
|
Ntaya
|
Tahyna
|
|
Anopheles A
|
Cotia
|
Ketapang
|
Nugget
|
Tamiami
|
|
Anopheles B
|
Cowbone Ridge
|
Keterah
|
Nyamanini
|
Tanga
|
|
Apeu
|
Csiro Village
|
Keuraliba
|
Nyando
|
Tanjong Rabok
|
|
Apoi
|
Cuiaba-
|
Keystone
|
O'nyong-nyong
|
Tataguine
|
|
Aride
|
D'Aguilar
|
Kismayo
|
Okhotskiy
|
Tehran
|
|
Arkonam
|
Dakar Bat
|
Klamath
|
Okola
|
Tembe
|
|
Aroa
|
Dengue-1
|
Kokobera
|
Olifantsvlei
|
Tembusu
|
|
Aruac
|
Dengue-2
|
Kolongo
|
Oriboca
|
Tensaw
|
|
Arumowot
|
Dengue-3
|
Koongol
|
Ossa
|
Tete
|
|
Aura
|
Dengue-4
|
Kotonkan
|
Pacora
|
Tettnang
|
|
Avalon
|
Dera Ghazi Khan
|
Kowanyama
|
Pacui
|
Thimiri
|
|
Abras
|
East equine encephalitis*
|
Kunjin
|
Pahayokee
|
Thottapalayam
|
|
Abu Hammad
|
Edge Hill< | |